Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group

Krishnansu Sujata Tewari; Michael Sill; Harry J. Long; Lois M. Ramondetta; Lisa Michelle Landrum; Ana Oaknin; Thomas J Reid; Mario M. Leitao; Helen E Michael; Bradley J. Monk

doi:10.1200/jco.2013.31.15_suppl.3

Back

Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group

Journal article

Peer reviewed

Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group

Krishnansu Sujata Tewari, Michael Sill, Harry J. Long, Lois M. Ramondetta, Lisa Michelle Landrum, Ana Oaknin, Thomas J Reid, Mario M. Leitao, Helen E Michael and Bradley J. Monk

Journal of clinical oncology, Vol.31(15_suppl), pp.3-3

05/20/2013

DOI: https://doi.org/10.1200/jco.2013.31.15_suppl.3

Abstract

Abstract only 3 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Sunday, June, 2, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News.

Metrics

10 Record Views

Details

Title: Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group
Creators: Krishnansu Sujata Tewari - University of California, Irvine Medical Center
Michael Sill - Gynecologic Oncology Group
Harry J. Long - Mayo Clinic in Arizona
Lois M. Ramondetta - The University of Texas MD Anderson Cancer Center
Lisa Michelle Landrum - University of Oklahoma Health Sciences Center
Ana Oaknin - Vall d'Hebron Hospital Universitari
Thomas J Reid - University of Cincinnati
Mario M. Leitao - Memorial Sloan Kettering Cancer Center
Helen E Michael - Carmel
Bradley J. Monk - Creighton University
Publication Details: Journal of clinical oncology, Vol.31(15_suppl), pp.3-3
Identifiers: 991005969146802656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article

Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group

Abstract

Related links

Metrics

Details